Is Wall Street Bullish or Bearish on DexCom Stock?

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company. It focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. With a market cap of $28.7 billion, DexCom operations span the Americas, Europe, and internationally.

Shares of the glucose monitor maker have substantially underperformed the broader market over the past year. Over the past 52 weeks, DXCM plummeted 32.4%, lagging behind the S&P 500 Index’s ($SPX) nearly 27% returns. In 2024 alone, DXCM is down 41.8% compared to SPX’s 16.8% gains on a YTD basis.